HuGE Literature Finder
Records
1
-
1
Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy. Expert opinion on drug metabolism & toxicology 2021 Jan . Zheng Yi, Deng Zheng, Tang Mimi, Cai P |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: